Spain is widely regarded as having one of the world’s best healthcare systems. Can a series of experiments in ‘value-based’ care help to make it even better? A new Science|Business report finds out
BSC has launched a new spin-off, ELEM Biotech, which will allow companies of medical technologies, pharmaceuticals, CROs and doctors to perform virtual simulations for the personalized treatment of some diseases.
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.